Goodwin Procter advised BridgeBio Pharma, Inc. on the deal.BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced its exclusive license agreement wit Bristol Myers Squibb to develop and commercialize…
BridgeBio Pharma’s License Agreement with Bristol Myers Squibb
